Multicenter phase II study of every-2 week gemcitabine and paclitaxel as first-line chemotherapy in patients with advanced urothelial tract cancer

4583 Background: Patients (pts) with transitional cell carcinoma (TCC) of the urothelium are not always amenable to cisplatin based chemotherapy. We have previously reported a 60% RR in patients wh...